Your browser doesn't support javascript.
loading
Somatic profile in lung cancers is associated to reproductive factors in never-smokers women: Results from the IFCT-1002 BioCAST study.
Fontaine-Delaruelle, C; Mazières, J; Cadranel, J; Mastroianni, B; Dubos-Arvis, C; Dumont, P; Monnet, I; Pichon, E; Locatelli-Sanchez, M; Dixmier, A; Coudert, B; Fraboulet, S; Foucher, P; Dansin, E; Baize, N; Vincent, M; Missy, P; Morin, F; Moro-Sibilot, D; Couraud, S.
Affiliation
  • Fontaine-Delaruelle C; Service de pneumologie aiguë spécialisée et cancérologie thoracique, hôpital Lyon Sud, institut de cancérologie des hospices civils de Lyon, Pierre-Bénite, France.
  • Mazières J; Service de pneumologie, université Paul-Sabatier, hôpital Larrey, centre hospitalier universitaire, Toulouse, France.
  • Cadranel J; Service de pneumologie, hôpital Tenon, AP-HP, Paris, France.
  • Mastroianni B; Service de pneumologie, institut de cancérologie des hospices civils de Lyon, hôpital Louis-Pradel, Bron, France.
  • Dubos-Arvis C; UCP d'oncologie thoracique, centre de lutte contre le cancer François-Baclesse, Caen, France.
  • Dumont P; Service de pneumologie, centre hospitalier de Chauny, Chauny, France.
  • Monnet I; OncoThoParisEst, service de pneumologie, CHI de Créteil, UPEC, Créteil, France.
  • Pichon E; Service de pneumologie, hôpital Bretonneau, CHRU de Tours, Tours, France.
  • Locatelli-Sanchez M; Service de pneumologie aiguë spécialisée et cancérologie thoracique, hôpital Lyon Sud, institut de cancérologie des hospices civils de Lyon, Pierre-Bénite, France.
  • Dixmier A; Service de pneumologie et oncologie thoracique, centre hospitalier régional d'Orléans, Orléans, France.
  • Coudert B; Oncologie médicale, centre G.F.-Leclerc, Dijon, France.
  • Fraboulet S; Service de pneumologie, hôpital Foch, Suresnes, France.
  • Foucher P; Fédération d'oncologie thoracique, hôpital du Bocage, CHU Dijon-Bourgogne, Dijon, France.
  • Dansin E; Département de cancérologie générale, centre Oscar-Lambret, Lille, France.
  • Baize N; Unité transversale de thérapeutiques innovantes en oncologie médicale (UTTIOM), CHU d'Angers, Angers, France.
  • Vincent M; Service de pneumologie et cancérologie thoracique, centre hospitalier Saint-Joseph et Saint-Luc, Lyon, et Minapath Développement Insavalor, Villeurbanne, France.
  • Missy P; Intergroupe francophone de cancérologie thoracique (IFCT), Paris, France.
  • Morin F; Intergroupe francophone de cancérologie thoracique (IFCT), Paris, France.
  • Moro-Sibilot D; Intergroupe francophone de cancérologie thoracique (IFCT), Paris, France; Clinique de pneumologie et oncologie thoracique, CHU Grenoble-Alpes, La Tronche, France.
  • Couraud S; Service de pneumologie aiguë spécialisée et cancérologie thoracique, hôpital Lyon Sud, institut de cancérologie des hospices civils de Lyon, Pierre-Bénite, France; EMR 3738 ciblage thérapeutique en oncologie, faculté de médecine Lyon Sud, université Lyon 1, Oullins, France. Electronic address: sebas
Respir Med Res ; 77: 58-66, 2020 Mar.
Article in En | MEDLINE | ID: mdl-32416585
ABSTRACT

BACKGROUND:

Lung cancer in women is on the rise, with a higher proportion occurring in lifelong never-smokers. Lung cancer in never-smokers (LCINS) exhibits a high frequency of driver oncogene alterations. In this study, we aimed to investigate whether exposure to reproductive factors in women with LCINS may modulate the molecular pattern.

METHODS:

All newly diagnosed LCINSs were included in a prospective, observational study (IFCT-1002 BioCAST). Each patient responded to a questionnaire including reproductive factors. Biomarker test results were also collected.

RESULTS:

Two hundred and sixty women were included in this analysis, and 166 alterations were characterized. EGFR mutation frequency proved greater among patients with late menarche (74% in age>14 vs. 40% and 41% for 12-14 and ≤12 years, respectively; P=0.020) and tended to decrease with increasingly late age at menopause. In multivariate analysis, EGFR mutation frequency increased by 23% per increment of 1 year of age at menarche (P=0.048), and by 9% for each year at age at first birth (P=0.035). ALK alteration frequency was greater in women with high parity (50% in≥5 vs. 12% and 7% for 1-4 and nulliparity, respectively; P=0.021).

CONCLUSION:

In a cohort of women LCINSs, female hormonal factors appear to impact molecular pattern.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Reproductive History / Lung Neoplasms Limits: Aged / Aged80 / Female / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: Respir Med Res Year: 2020 Type: Article Affiliation country: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Reproductive History / Lung Neoplasms Limits: Aged / Aged80 / Female / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: Respir Med Res Year: 2020 Type: Article Affiliation country: France